-
Z648615-100mgZaurategrast ethyl ester (CDP323), the ethyl ester proagent of CT7758 , is a α4β1 / α4β7 integrin antagonist used for the treatment of inflammatory and autoimmune disorders .In VitroZaurategrast ethyl ester (CDP323), an ethyl ester prodrug of
-
Z648615-10mgZaurategrast ethyl ester (CDP323), the ethyl ester proagent of CT7758 , is a α4β1 / α4β7 integrin antagonist used for the treatment of inflammatory and autoimmune disorders .In VitroZaurategrast ethyl ester (CDP323), an ethyl ester prodrug of
-
Z648615-25mgZaurategrast ethyl ester (CDP323), the ethyl ester proagent of CT7758 , is a α4β1 / α4β7 integrin antagonist used for the treatment of inflammatory and autoimmune disorders .In VitroZaurategrast ethyl ester (CDP323), an ethyl ester prodrug of
-
Z648615-50mgZaurategrast ethyl ester (CDP323), the ethyl ester proagent of CT7758 , is a α4β1 / α4β7 integrin antagonist used for the treatment of inflammatory and autoimmune disorders .In VitroZaurategrast ethyl ester (CDP323), an ethyl ester prodrug of
-
Z648615-5mgZaurategrast ethyl ester (CDP323), the ethyl ester proagent of CT7758 , is a α4β1 / α4β7 integrin antagonist used for the treatment of inflammatory and autoimmune disorders .In VitroZaurategrast ethyl ester (CDP323), an ethyl ester prodrug of
-
Z655498-1mlZaurategrast ethyl ester (CDP323), the ethyl ester proagent of CT7758 , is a α4β1 / α4β7 integrin antagonist used for the treatment of inflammatory and autoimmune disorders .In VitroZaurategrast ethyl ester (CDP323), an ethyl ester prodrug of
-
I658694-10mgα2β1 Integrin Ligand Peptide TFA interacts with the α2β1 integrin receptor on the cell membrane and mediates extracellular signals into cells. It is a potential antagonist of collagen receptors.Appearance:SolidIn Vitro:α2β1 Integrin Ligand Peptide
-
I658694-1mgα2β1 Integrin Ligand Peptide TFA interacts with the α2β1 integrin receptor on the cell membrane and mediates extracellular signals into cells. It is a potential antagonist of collagen receptors.Appearance:SolidIn Vitro:α2β1 Integrin Ligand Peptide
-
I658694-5mgα2β1 Integrin Ligand Peptide TFA interacts with the α2β1 integrin receptor on the cell membrane and mediates extracellular signals into cells. It is a potential antagonist of collagen receptors.Appearance:SolidIn Vitro:α2β1 Integrin Ligand Peptide
-
I647197-10mgα5β1 integrin agonist-1, acting as α5β1 integrin agonist, is able to selectively deliver 5-FU into tumor cells, successfully leading to cancer cell death.Form:Solid
-
I647197-1mgα5β1 integrin agonist-1, acting as α5β1 integrin agonist, is able to selectively deliver 5-FU into tumor cells, successfully leading to cancer cell death.Form:Solid
-
I647197-5mgα5β1 integrin agonist-1, acting as α5β1 integrin agonist, is able to selectively deliver 5-FU into tumor cells, successfully leading to cancer cell death.Form:Solid